CClinicalTrials.gg
CompletedNCT04812353Updated Jul 10, 2026

Foot and Ankle Arthrodesis or Osteotomy With Io-Fix Type Fixation

An interventional study of Follow-up of Io-Fix type fixation in Foot and Ankle Arthrodesis and Foot and Ankle Osteotomy, sponsored by Universitaire Ziekenhuizen KU Leuven. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 6 years 11 months after the study started (first participant enrolled Apr 2014, registered Mar 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The recovery of foot and ankle arthrodesis and osteotomy is still plagued by the problem of delayed consolidation or even pseudo-arthrosis. To date, the foot and ankle unit of UZ Leuven is using a state of the art system, called the Io-Fix system, to optimize the biomechanical stability.

However, the current literature lacks studies assessing and quantifying the advantages of the Io-Fix system. Objective presentations about the use of, and (early) results are currently missing. Therefore, the investigators want to take their responsibility to objectively investigate whether they can confirm and quantify the expected positive results of using the Io-Fix system. Subsequently, the investigators want to search for eventual unexpected problems with Io-Fix.

Read the detailed description

The recovery of foot and ankle arthrodesis and osteotomy is still plagued by the problem of delayed consolidation or even pseudo-arthrosis. Some known risk factors for delayed consolidation are inherent to the patient and /or cannot be easily corrected by the surgeon: smoking, diabetes mellitus, use of NSAIDS, etc. Many other biological risk factors are well known. The fusion rate is one of these factors. This factor is influenced by the mechanical stability and compression at the level of arthrodesis. The right alignment till the moment of consolidation is an important factor as well.

Currently, two concepts leading to a better fusion rate are under investigation. First, research is done to optimize the local biological factors by using concentrated growth factors. Second, researchers are working towards optimal biomechanical stability and compression by further developing per-operative osteosynthesis material.

Following the optimal biomechanical stability concept, the following innovation was recently released: the Io-Fix system of Extremity Medical L.L.C. (Parsippany , NJ). This state of the art system has clear advantages compared to other systems. Based on the well-expected advantages, the Foot and Ankle unit of UZ Leuven has been using this system since more than one year. The initial subjective results with Io-Fix are strongly positive.

However, the current literature lacks studies assessing and quantifying the advantages of the Io-Fix system. Objective presentations about the use of, and (early) results are currently missing. Therefore, the investigators want to take their responsibility to objectively investigate whether they can confirm and quantify the expected positive results of using the Io-Fix system. Subsequently, the investigators want to search for eventual unexpected problems with Io-Fix.

However, the investigators believe that a larger study groups within a prospective framework with a longer follow-up is mandatory.

02

Conditions studied

  • Foot and Ankle Arthrodesis
  • Foot and Ankle Osteotomy

Browse trials for

Keywords

  • Arthrodesis
  • Osteotomy
  • Io-Fix system
03

In context

Ankylosis

35 studies on the registry are indexed under Ankylosis; 17 are open to participants now.

This study's enrollment of 208 is above the median of 92 across 19 interventional studies indexed under Ankylosis.

Browse Ankylosis studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 928 studies on the registry; 261 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being routinely scheduled for a reconstructive surgical procedure for the following indications or involving the following type of procedure

    1. Any reconstructive procedure for Pes Planus, Pes Plano-valgus, or Posterior Tibial Tendon Dysfunction
    2. Tibio-talar arthrodesis or prosthesis
    3. Sub-talar -and/or (partial) Chopart - and/or Triple arthrodesis
    4. Pantalar arthrodesis with or without inclusion of the Chopart joint

Exclusion criteria

Exclusion Criteria:

  • Age under 18
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
208 participants (actual)

Study arms

  • Other
    Foot and ankle arthrodesis or osteotomy

    Patients who underwent a foot- or ankle reconstruction surgery using the Io-Fix system

    Other: Follow-up of Io-Fix type fixation

Interventions

  • OtherFollow-up of Io-Fix type fixation

    Follow-up of patients who underwent a foot- or ankle reconstruction surgery using the Io-Fix system

06

What researchers measure

Primary outcomes

  1. Radiological and clinical evaluation

    Radiological and clinical evaluation will be combined to determine the fusion rate within a measured time span

    Time frame: within a period of 1 year

Secondary outcomes

  1. Short Form 36 Health Survey Questionnaire (SF-36)

    To capture patients' perceptions of their own health and well-being

    Time frame: within a period of 1 year

  2. American Orthopedic Foot and Ankle Score (AOFAS)

    To measure the outcome of treatment in patients who sustained a complex ankle or hindfoot injury

    Time frame: within a period of 1 year

07

Study locations

1 site
  • UZ Leuven
    Leuven, Vlaams-Brabant 3000, Belgium
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04812353
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Responsible party
Sponsor
First posted
Mar 23, 2021
Start date
Apr 1, 2014
Primary completion
Sep 24, 2021
Completion
Sep 24, 2021
Last update
Jul 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion